| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.99M | 14.18M | 18.73M | 11.73M | 9.56M | 6.44M |
| Gross Profit | 3.83M | 4.94M | 5.61M | 4.21M | 5.01M | 3.10M |
| EBITDA | -3.80M | -3.23M | -3.71M | -2.82M | -398.00K | -2.04M |
| Net Income | -4.78M | -3.83M | -3.83M | -2.41M | -871.00K | -2.06M |
Balance Sheet | ||||||
| Total Assets | 41.61M | 33.19M | 23.12M | 20.45M | 16.79M | 14.01M |
| Cash, Cash Equivalents and Short-Term Investments | 1.63M | 5.83M | 783.00K | 4.07M | 2.35M | 1.49M |
| Total Debt | 19.75M | 7.09M | 474.00K | 1.35M | 2.02M | 2.22M |
| Total Liabilities | 30.10M | 18.10M | 9.69M | 5.68M | 5.36M | 7.00M |
| Stockholders Equity | 11.51M | 15.09M | 13.43M | 14.77M | 11.43M | 7.01M |
Cash Flow | ||||||
| Free Cash Flow | -13.22M | -6.59M | -4.47M | -2.98M | -3.42M | -1.14M |
| Operating Cash Flow | -13.06M | -5.54M | -2.86M | -2.22M | -3.13M | -988.00K |
| Investing Cash Flow | -912.00K | -1.02M | -1.60M | -766.00K | -296.00K | -90.00K |
| Financing Cash Flow | 6.05M | 7.74M | 1.23M | 4.69M | 4.28M | 1.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £52.58M | 10.81 | 17.36% | 4.20% | 5.46% | 12.34% | |
75 Outperform | £466.28M | 27.44 | 26.93% | ― | 121.45% | 345.83% | |
69 Neutral | £175.33M | 18.51 | 12.09% | 0.95% | 22.72% | -8.82% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | £43.12M | -17.38 | 2.30% | 2.02% | 20.83% | ― | |
52 Neutral | £37.37M | 5.88 | 2.29% | 3.67% | -21.33% | -11.35% | |
49 Neutral | £27.09M | -2.04 | -35.93% | ― | -13.95% | 4.29% |